참고문헌
- E. Saltiel, A. G. Ellrodt, J. P. Monk and M. S. Langley, Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension, Drugs 36, 387-428 (1988) https://doi.org/10.2165/00003495-198836040-00002
- P. H. Dunselman and B. Edgar, Felodipine clinical pharmacokinetics, Clin. Pharmacokinet., 21, 418-430 (1991) https://doi.org/10.2165/00003088-199121060-00003
- E. Matianne, L. Jan-Erik and S. Mats, New pharmaceutical formulation, EUPO-Patent, 01113786 (2001)
- C. K. Kim and J. S. Park, Solubility enhances for oral drug delivery: can chemical structure manipulation be avoided? Am. J. Drug Del., 2, 113-130 (2004) https://doi.org/10.2165/00137696-200402020-00004
-
I. K. Chun and J. H. Park, Preparation and controlled release of microcapsules containing ketoprofen-
${\beta}$ -cyclodextrin solid dispersion, J. Kor. Pharm. Sci., 22, 33-40 (1992) -
J. Mielcarek, Studies on inclusion complex of felodipine with
${\beta}$ -cyclodextrin, J. Inc. Phenom. Mol. Rec. Chem., 30, 243-252 (1998) https://doi.org/10.1023/A:1007960725895 - E. Karavas, E. Georgarakis, D. Bikiaris, T. Thomas, V. Katsos and A. Xenakis, Hydrophilic matrices as carriers in felodipine solid dispersion systems, Progr. Colliod. Polm. Sci., 118, 149-152 (2001) https://doi.org/10.1007/3-540-45725-9_34
- Y. S. Gil, S. C. Hong, C. H. Yu, H. J. Shin and J. S. Kim, Improvement of dissolution rate of felodipine suing solid dispersion and its sustained release oral dosage form, J. Kor. Pharm. Sci., 32, 185-190 (2002)
- J. K. Lee, S. W. Yang, B. S. Lee, H. R. Jeon, J. Lee, Y. W. Choi, Formulation of sustained-release tablets of felodipine using hydrophilic polymers and non-ionic surfactants, J. Kor. Pharm. Sci., 36, 271-276 (2006)
- R. Bodmeier and O. Paeratakul, Multiparticulate Oral Drug Delivery, Marcel Dekker, New York, U.S.A., pp. 143-156 (1994)
- A. Dashevsky, K. Wagner and R. Bodmeier, pH-independent release of a basic drug from pellets coated with the extended release polymer dispersion Kollicoat SR 30 D and the enteric polymer dispersion Kollicoat MAE 30 DP, Eur. J. Pharm. Biopharm., 58, 45-49 (2004) https://doi.org/10.1016/j.ejpb.2004.03.013
- N. Sinchaipanid, V. Junyaprasert and A. Mitrevej, Application of hot-melt coating for controlled release of propranolol hydrochloride pellets, Powder Technol., 141, 203-209 (2004) https://doi.org/10.1016/j.powtec.2004.02.008
- A. Dashevsky, K. Wagner, K. Kolter and R. Bodmeier, Physicochemical and release properties of pellets coated with Kollicoat SR 30 D, a new aqueous polyvinyl acetate dispersion for extended release, Int. J. Pharm., 290, 15-23 (2005) https://doi.org/10.1016/j.ijpharm.2004.10.024
- J. Hamdani, A.J. Moes, K. Amighi, Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization, Int. J. Pharm., 322, 96-103 (2006) https://doi.org/10.1016/j.ijpharm.2006.05.052
- J. H. Yang, S. B. La, Y. I. Kim and N. S. Kim, Bioavailability of microspheres containing felodipine, Yakhak Hoeji, 44, 440-447 (2000)
- R. J. Harwood, Polymethacrylates, Handbook of Pharmaceutical Excipients 3rd edition, American Pharmaceutical Association, The Pharmaceutical Press, pp. 401-406 (2000)
-
Rohm Pharma, Information Sheet, 'Eudragit
$^{\circledR}$ RL' (1998) -
Rohm Pharma, Information Sheet, 'Eudragit
$^{\circledR}$ RS' (1998) - A. Hoegholm, N. Wiinberg, E. Rasmussen and P. E. Nielsen, Comparative effects of amlodipine and felodipine ER on office and ambulatory blood pressure in patients with mild to moderate hypertension. Danish Multicentre Group, J. Hum. Hypertens. 9, S25-28 (1995)